Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Onconase/interferon combination exerts synergistic antitumor activity in vitro

July 14, 1999

NeXstar begins enrolling patients in U.S. phase I trial of NX-211

July 14, 1999

Selected purine analogues tested as angiogenesis inhibitors

July 14, 1999

Inhibitors of protein geranylgeranylation developed at Baldacci as antitumor agents

July 13, 1999

Indena presents novel paclitaxel derivatives with excellent antitumor activity

July 13, 1999

Structurally novel antitumor and immunosuppressive compounds from Klinge

July 13, 1999

Orphan Medical, Pierre Fabre sign letter of intent to license Busulfex

July 12, 1999

Antitumor and antibacterial compound isolated from cultures of Streptomyces at Kyowa Hakko

July 12, 1999

MetXia-P450 for GDEPT of cancer

July 9, 1999

Gene therapy AD21 evaluated in phase I study in cancer patients

July 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...